Upcoming Events and meetings
This EMCHD 2019 meeting represents a new edition of a very successful series of congresses in which the expanding role of complement in human disease and the excitement of novel diagnostic and therapeutic developments will be updated.
The European Society for Organ Transplantation supports its members gathering together (Non) European Tx Professionals at the Congress and events #PoweredByESOT
Speaker – Professor Peter Garred, University of Copenhagen
Wednesday 27 November 2019, 16:00-17:00
University of Cambridge
Annual meetings of Complement UK serve two key purposes: to deliver a strong training element; and to foster collaborative research in specified areas.
This year’s event will focus on Complement Diagnostics and Therapeutics.
The first day is a teaching day focused on trainees, students and junior Post Docs. There will be introductory lectures on complement, followed by a choice of tutorials covering many aspects of basic complement biology and biochemistry, and the role of complement in disease. The symposium on the second day will expand on a specific research theme, which this year is the role of complement in diagnostics and therapeutics.
Following the tutorials, there will be a guest talk by Professor Sir Keith Peters.
*Registration for this meeting will open in September 2019*
Our sponsors:
PLATINUM:
BRONZE:
This conference aims to bring together academic and industry scientists and clinical development experts who are focused on contemporary and emerging aspects of complement-mediated disease pathogenesis and the development of therapeutics that modulate this system in a beneficial manner. Topics discussed during the conference include: Molecular mechanisms and targets in complement-related diseases; Novel inhibitors & pipeline compounds; Haematological disorders; Organ & cell transplantation, I/R injury and chronic rejection; Kidney diseases; Neurological & ocular diseases; Acute and chronic inflammatory disorders; Infectious diseases & sepsis; Cancer; Informative complement biomarkers in therapeutic development; Novel and unexpected indications